In contrast, ephrinB2 is highly expressed on the vascular endothelium, and its knockout in this compartment suppresses tumor growth, decreases intratumoral infiltration of regulatory T cells (Tregs), and increases activation of CD8+ T cells (Bhatia et al., 2022). This evidence concerns the gene EFNB2 and neoplasm.